Please login to the form below

Not currently logged in
Email:
Password:

treatment access

This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.

Pfizer's Ibrance scores second-line breast cancer approval via NICE’s Cancer Drugs Fund

Pfizer's Ibrance scores second-line breast cancer approval via NICE’s Cancer Drugs Fund

We know how important it is for women to have access to treatment options that can delay the progression of their disease and help them live a normal life for longer, ... However, it then re-considered its decision after Pfizer submitted an ‘improved

Latest news

More from news
Approximately 1 fully matching, plus 209 partially matching documents found.

Latest Intelligence

  • As the opioid crisis grabs the headlines, the search for safe treatments continues As the opioid crisis grabs the headlines, the search for safe treatments continues

    science. Access to healthcare in heightened risk groups where people have low self-esteem and do not seek treatment, combined with stigmatising methods of controlled supervision and reduced funding for support ... They reach about 50% of those people who

  • Rare diseases: redefining medical communications Rare diseases: redefining medical communications

    Low levels of clinical awareness and expertise, small patient populations, paucity of data, and access to treatment are all factors that drive the need for new approaches, compared with those used ... Access to treatment. The demonstration of value is

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    Diarmaid McDonald is lead organiser of Just Treatment, a UK-based patient activist group which is challenging the government to take whatever steps necessary to ensure access to new medicines at ... Diarmaid McDonald, lead organiser, Just Treatment. The

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    with a rare condition for which there is no diagnosis, or no treatment, or where there is no access to new therapies on the NHS. ... greater access to diagnosis and treatment.

  • Gene therapy market access Q&A Gene therapy market access Q&A

    Jesper Jorgensen, Health Economics and Market Access Manager, Cell and Gene Therapy Catapult. ... Getting this right is extremely important as a marketing authorisation is of little use to anyone if patients can’t access the treatment.

More from intelligence
Approximately 1 fully matching, plus 46 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 24 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics